Kushner. Obesidad_1ed

Capítulo 4 • Manejo conjunto de las comorbilidades relacionadas con obesidad: evaluación, tratamiento y supervisión 77

37. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2020. Diabetes Care . 2019;42(suppl 1):S90- S102. doi:10.2337/dc19-S009 38. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab . 2013;98(12):4565-4592. doi:10.1210/jc.2013-2350 39. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syn- drome in an unselected population. J Clin Endocrinol Metab . 2004;89(6):2745-2749. doi:10.1210/jc.2003-032046 40. Sam S. Obesity and polycystic ovary syndrome. Obes Manag . 2007;3(2):69-73. doi:10.1089/obe.2007.0019 41. Castillo-Martínez L, López-Alvarenga JC, Villa AR, González-Barranco J. Menstrual cycle length disorders in 18- to 40-y-old obese women. Nutrition . 2003;19(4):317- 320. doi:10.1016/s0899-9007(02)00998-x 42. Lake JK, Power C, Cole TJ. Women’s reproductive health: the role of body mass index in early and adult life. Int J Obes Relat Metab Disord . 1997;21(6):432-438. doi:10.1038/ sj.ijo.0800424 43. Practice Committee of the American Society for Reproductive Medicine. Obesity and reproduction: a committee opinion. Fertil Steril . 2015;104(5):1116-1126. doi:10.1016/j.fertnstert.2015.08.018 44. Fernandez CJ, Chacko EC, Pappachan JM. Male obesity- related secondary hypogonadism – pathophysiology, clinical implications and management. Eur Endocrinol . 2019;15(2):83-90. doi:10.17925/EE.2019.15.2.83 45. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an endocrine soci- ety clinical practice guideline. J Clin Endocrinol Metab . 2018;103(5):1715-1744. doi:10.1210/jc.2018-00229 46. Ravesloot MJ, van Maanen JP, Hilgevoord AA, van Wagensveld BA, de Vries N. Obstructive sleep apnea is underrecognized and underdiagnosed in patients undergoing bariatric surgery. Eur Arch Oto-Rhino- Lar yngol . 2012;269(7):1865-1871. doi :10.1007/ s00405-012-1948-0 47. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep- disordered breathing. J Am Med Assoc . 2000;284(23):3015- 3021. doi:10.1001/jama.284.23.3015 48. US Preventive Services Task Force; Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for obstruc- tive sleep apnea in adults: US Preventive Services Task Force recommendation statement. J Am Med Assoc . 2017;317(4):407-414. doi:10.1001/jama.2016.20325 49. NetzerNC, StoohsRA,NetzerCM, ClarkK, Strohl KP.Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med . 1999;131(7):485- 491. doi:10.7326/0003-4819-131-7-199910050-00002 50. Johns MW. A new method for measuring daytime sleepi- ness: the Epworth sleepiness scale. Sleep . 1991;14(6):540- 545. doi:10.1093/sleep/14.6.540 51. Chung F, Abdullah HR, Liao P. STOP-bang question- naire: a practical approach to screen for obstructive sleep apnea. Chest . 2016;149(3):631-638. doi:10.1378/ chest.15-0903 52. Epstein LJ, Kristo D, Strollo PJ, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med . 2009;5(3):263-276.

53. Kapur VK, Auckley DH, Chowdhuri S. et al. Clinical prac- tice guideline for diagnostic testing for adult obstructive sleep apnea: an American academy of sleep medicine clin- ical practice guideline. J Clin Sleep Med . 2017;13(3):479- 504. doi:10.5664/jcsm.6506 54. Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. J Am Med Assoc . 2020;323(14):1389-1400. doi:10.1001/jama.2020.3514 55. Mokhlesi B, Masa JF, Brozek JL, et al. Evaluation and man- agement of obesity hypoventilation syndrome. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med . 2019;200(3):e6-e24. doi:10.1164/ rccm.201905-1071ST 56. Kaw R, Hernandez AV, Walker E, Aboussouan L, Mokhlesi B. Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanal- ysis of cohort studies. Chest . 2009;136(3):787-796. doi:10.1378/chest.09-0615 57. Katz PO, Gerson LB, Vela MF. Guidelines for the diag- nosis and management of gastroesophageal reflux dis- ease. Am J Gastroenterol . 2013;108(3):308-328; quiz 329. doi:10.1038/ajg.2012.444 58. Emerenziani S, Rescio MP, Guarino MP, Cicala M. Gastro- esophageal reflux disease and obesity, where is the link? World J Gastroenterol . 2013;19(39):6536-6539. doi:10.3748/ wjg.v19.i39.6536 59. Camilleri M, Malhi H, Acosta A. Gastrointestinal compli- cations of obesity. Gastroenterology . 2017;152(7):1656-1670. doi:10.1053/j.gastro.2016.12.052 60. Chalasani N, Younossi Z, Lavine JE, et al. The diagno- sis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology . 2018;67(1):328-357. doi:10.1002/hep.29367 61. Liu B, Balkwill A, Spencer E, Beral V; Million Women Study Collaborators. Relationship between body mass index and length of hospital stay for gallbladder disease. J Public Health (Oxf) . 2008;30(2):161-166. doi:10.1093/pubmed/fdn011 62. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab . 2004;89(6):2583-2589. doi:10.1210/jc.2004-0535 63. Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med . 1995;98(2):115- 117. doi:10.1016/S0002-9343(99)80394-5 64. Vincent HK, Heywood K, Connelly J, Hurley RW. Obesity and weight loss in the treatment and prevention of oste- oarthritis. PM R . 2012;4(5 suppl):S59-S67. doi:10.1016/j. pmrj.2012.01.005 65. Bartlett S. Role of Body Weight in Osteoarthritis . Johns Hopkins Arthritis Center. AccessedDecember 2019. https://www.hop- kinsmedicine.org/health/conditions-and-diseases/arthritis 66. Felson DT, Chaisson CE. Understanding the relation- ship between body weight and osteoarthritis. Baillieres Clin Rheumatol . 1997;11(4):671-681. doi:10.1016/ s0950-3579(97)80003-9 67. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol . 2020;72(2):220- 233. doi:10.1002/art.41142

68. Li W, Ayers DC, Lewis CG, Bowen TR, Allison JJ, Franklin PD. Functional gain and pain relief after total joint replacement according to obesity status. J Bone Joint Surg Am . 2017;99(14):1183-1189. doi:10.2106/JBJS.16.00960 SAMPLE